ICRA upgrades long-term rating to ICRA A+ for bank facilities of Windlas Biotech; Stock gains
The credit rating agency also reaffirms the short-term rating of the company at ICRA A1.
from India Infoline News Service https://ift.tt/3u7hNcc
from India Infoline News Service https://ift.tt/3u7hNcc
Comments